Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients

Affiliations

• ¹ Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
• ² Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
• ³ Department of Medical Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan 450008, China.
• ⁴ Department of Medical Oncology, Hubei Cancer Hospital, Wuhan 430079, China.
• ⁵ Department of Medical Oncology, Shandong Cancer Hospital, Jinan, Shandong 250117, China.
• ⁶ Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
• ⁷ Department of Medical Oncology, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, China.
• ⁸ Department of Medical Oncology, The Second Affiliated Hospital of SooChow University, Suzhou, Jiangsu 215008, China.
• ⁹ Department of Medical Oncology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China.
• ¹⁰ Department of Medical Oncology, Liaoning Cancer Hospital, Cancer Hospital of China Medical University, Shenyang, Liaoning 110042, China.
• ¹¹ Department of Medical Oncology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan 453000, China.
• ¹² Department of Medical Oncology, Zhejiang Cancer Hospital, Institute of Cancer and Basic Medicine, Chinese Academy of Sciences, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.